Publication

Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)

BMJ Open 3(6):e072216, 2023. Møller M, Borg R, Bressendorff I, Fink LN, Gravesen E,Jensen KH, Hansen T, Krustrup D, Persson F, Rossing P, Sembach FE, Thuesen ACB, Hansen D.

Subjects

Human Chronic kidney disease (CKD)Blood biochemistry Diabetic kidney disease (DKD)Bioinformatics Clinical trial Immunohistochemistry Kidney biopsy Kidney morphometry Next-generation sequencing RNA sequencing

Share this page

Resource Library

Related resources

Poster

Adenine-induced mouse model of CKD rapidly develops declined kidney function, renal fibrosis, muscle wasting and anemia

Poster

Whole-kidney 3D imaging and transcriptome assessment in the UNx db/db (renin-AAV) mouse model of diabetic nephropathy

Poster

Renal cell-type associated therapeutic effects of semaglutide in a mouse model of hypertension accelerated diabetic kidney disease

Webinar

Nephroprotective effects of semaglutide in a preclinical model of hypertensive diabetic kidney disease

Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)

Subjects

Related resources

For further information

Contact us

Gubra